Advertisement
Screener

AYTU BIOPHARMA, INC (AYTU) Proceeds from Sale of Other Productive Assets

2.2 / 5 stars · 38/87 Roast Me

AYTU BIOPHARMA, INC Proceeds from Sale of Other Productive Assets

AYTU BIOPHARMA, INC (AYTU) reported Proceeds from Sale of Other Productive Assets of $1.75 million for the 12-month period ending 2017-06-30, per its 10-K filed 2017-08-31.

Discontinued › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleOfOtherProductiveAssets · last filed 2017-08-31

  • AYTU BIOPHARMA, INC proceeds from sale of other productive assets for the quarter ending 2017-06-30 was $0.00.
  • AYTU BIOPHARMA, INC proceeds from sale of other productive assets for the quarter ending 2016-06-30 was $0.00.
  • AYTU BIOPHARMA, INC proceeds from sale of other productive assets for fiscal 2017 was $1.75M.
  • AYTU BIOPHARMA, INC proceeds from sale of other productive assets for fiscal 2016 was $0.00.
Period endProceeds from Sale of Other Productive Assets 3 monthProceeds from Sale of Other Productive Assets 9 monthProceeds from Sale of Other Productive Assets 12 month
2017-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31
$1.75M
10-K · filed 2017-08-31
2017-03-31$1.75M
10-Q · filed 2017-05-11
2016-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31
$0.00
10-K · filed 2017-08-31
2016-03-31$0.00
10-Q · filed 2017-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77